HealthEquity (HQY) Tops Q2 EPS by 16c, provides guidance

HealthEquity (NASDAQ: HQY) reported Q2 EPS of $1.08, $0.16 better than the analyst estimate of $0.92. Revenue for the quarter came in at $325.8 million versus the consensus estimate of $320.74 million.

GUIDANCE:

HealthEquity sees FY2026 EPS of $3.74-$3.91, versus the consensus of $3.73. HealthEquity sees FY2026 revenue of $1.29-1.31 billion, versus the consensus of $1.305 billion.

For earnings history and earnings-related data on HealthEquity (HQY) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Baldwin Insurance (BWIN) call put ratio 5.9 calls to 1 put with a focus on July 20 and 22.50 calls
• AIG (AIG) call put ratio 4 calls to 1 put with a focus on June 26 weekly calls as share price up 3.9%